BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
England and Wales Court of Appeal (Civil Division) Decisions |
||
You are here: BAILII >> Databases >> England and Wales Court of Appeal (Civil Division) Decisions >> Protomed Ltd v Medication Systems Ltd & Anor [2013] EWCA Civ 1205 (25 July 2013) URL: http://www.bailii.org/ew/cases/EWCA/Civ/2013/1205.html Cite as: [2013] EWCA Civ 1205 |
[New search] [Printable RTF version] [Help]
ON APPEAL FROM CHANCERY DIVISION, PATENTS COURT
(MR JUSITCE MANN)
Strand London WC2A 2LL |
||
B e f o r e :
LORD JUSTICE ELIAS
LORD JUSTICE LEWISON
____________________
PROTOMED LIMITED | Appellant | |
v | ||
MEDICATION SYSTEMS LIMITED AND ANOTHER | Respondent |
____________________
WordWave International Limited
A Merrill Communications Company
165 Fleet Street, London EC4A 2DY
Tel No: 020 7404 1400 Fax No: 020 7831 8838
Official Shorthand Writers to the Court)
Mr Roger Wyand QC (instructed by Brown Rudnick) appeared on behalf of the Respondent
____________________
Crown Copyright ©
LORD JUSTCIE LEWISON:
"Conventionally, and particularly in care homes, it is necessary for large numbers of such bottles to be stored, and this takes up considerable space. Furthermore, since the medication is contained in a large bottle then as the quantity in the bottle diminishes an increasing air space above the liquid is created which can adversely affect the chemical properties of the medicine.
It is an object of the present invention to provide a system of accurately and conveniently packaging individual doses of medication, whether in liquid or tablet form, and which is more easily managed in a safe and convenient manner, thus substantially avoiding the aforementioned difficulties."
"For example, each tray may be charged with substances of different kinds such as tablets, capsules and liquids or ointments, a feature which has not hitherto been possible with blister packaging or the like.
Also, the pots with the removable film 23 avoid the conventional problem, with foil covered blisters, of having to eject tablets or capsules by supplying sufficient force to eject them through the foil, often resulting in lost or spoiled medication.
Additionally, the pot serves as a medicine cup in itself, thus avoiding the need for foil packed tablets or capsules to be pre-dispensed into a medicine cup.
The sealing process is less likely to damage or contaminate the medication which, in the pot, is separated from the sealing source to a much greater extent than with blister packaging.
The individual pots can be removed selectively to allow medication to be removed from the tray and taken away by the patient for use elsewhere and at a later time."
"a monitored dosing system container for discretely packaging a plurality of quantities of one or more fluid or solid medications, and comprising a tray having individual spaced compartments, a plurality of pots individually removeably received within the respective compartments, wherein each pot has an upper flange and is adapted to contain a medication to be packaged, means to releaseably retain the pots in the compartments prior to intended release, and means to sealingly retain the medication in pots prior to its intended use; wherein the means to sealingly retain the medication in pots comprises a flexible perforated sheet of non-permeable material placed over the filled tray and sealingly attached to and across an otherwise open top of each pot, and wherein the perforations coincide with the outer peripheries of the pots so as to define individual sealed films across each pot, and once the pot is removed the sealed pot can be peeled off the upper flange to open the pot."
"It therefore seems to me that, on the material and arguments placed before me at the hearing of the application, the claimant's arguments on infringement are wrong and the defendants' arguments are right. That, however, by itself might not be sufficient to enable the defendants to succeed. The question is whether I am satisfied that the defendants are so right that there is no arguable case against them on infringement. I consider that that is indeed the case. This is not a complicated patent. There is no real prospect that any relevant evidence or other material would be adduced at a trial which would assist in the exercise of construing Claim 1. The exercise of construing it so as to judge the infringing nature, or otherwise, of the defendants' product is sufficiently straightforward to allow me to reach a clear view on the material that I have. My clear view is that the claimant does not have an arguable case on infringement. In those circumstances, the claimant does not get over the first hurdle in American Cynamid and is therefore not entitled to an interim injunction."
"The use of such expressions as 'a probability', 'a prima facie case', or 'a strong prima facie case' in the context of the exercise of a discretionary power to grant an interlocutory injunction leads to confusion as to the object sought to be achieved by this form of temporary relief. The court no doubt must be satisfied that the claim is not frivolous or vexatious, in other words, that there is a serious question to be tried.
It is no part of the court's function at this stage of the litigation to try to resolve conflicts of evidence on affidavit as to facts on which the claims of either party may ultimately depend nor to decide difficult questions of law which call for detailed argument and mature considerations. These are matters to be dealt with at the trial. One of the reasons for the introduction of the practice of requiring an undertaking as to damages upon the grant of an interlocutory injunction was that 'it aided the court in doing that which was its great object, viz. abstaining from expressing any opinion upon the merits of the case until the hearing' ... So unless the material available to the court at the hearing of the application for an interlocutory injunction fails to disclose that the plaintiff has any real prospect of succeeding in his claim for a permanent injunction at the trial, the court should go on to consider whether the balance of convenience lies in favour of granting or refusing the interlocutory relief that is sought."
"Purposive construction" does not mean that one is extending or going beyond the definition of the technical matter for which the patentee seeks protection in the claims. The question is always what the person skilled in the art would have understood the patentee to be using the language of the claim to mean. And for this purpose, the language he has chosen is usually of critical importance. The conventions of word meaning and syntax enable us to express our meanings with great accuracy and subtlety and the skilled man will ordinarily assume that the patentee has chosen his language accordingly. As a number of judges have pointed out, the specification is a unilateral document in words of the patentee's own choosing. Furthermore, the words will usually have been chosen upon skilled advice. The specification is not a document inter rusticos for which broad allowances must be made. On the other hand, it must be recognised that the patentee is trying to describe something which, at any rate in his opinion, is new; which has not existed before and of which there may be no generally accepted definition. There will be occasions upon which it will be obvious to the skilled man that the patentee must in some respect have departed from conventional use of language or included in his description of the invention some element which he did not mean to be essential. But one would not expect that to happen very often."
"I shall say in a moment why I agree with the Court of Appeal, but I want first to emphasise a point I have already made about the use of the Protocol questions. The determination of the extent of protection conferred by a European patent is an examination in which there is only one compulsory question, namely that set by article 69 and its Protocol: what would a person skilled in the art have understood the patentee to have used the language of the claim to mean? Everything else, including the Protocol questions, is only guidance to a judge trying to answer that question. But there is no point in going through the motions of answering the Protocol questions when you cannot sensibly do so until you have construed the claim. In such a case - and the present is in my opinion such a case - they simply provide a formal justification for a conclusion which has already been reached on other grounds."
LORD JUSTICE ELIAS:
"I do not suggest that Mr Wilson's argument was always hopeless and bound to fail. There was, and I do not seek to do him an injustice, some sort of argument there. Although I am satisfied as to what my decision is, since it is basically a determination of the true construction of this patent upon which it may be possible to reach a different view, I shall give Mr Wilson permission to appeal."
LORD JUSTICE MOORE-BICK:
Order: Appeal dismissed